Precision medicine has fundamentally changed how diseases are defined and how therapies are developed — shifting eligibility from clinical phenotype to molecula...
Continue reading
On a recent episode of The Genetics Podcast, Patrick spoke with Tim Spector, Professor of Genetic Epidemiology at King’s College London and co-founder of Zoe. T...
Continue reading
Biomarker testing is foundational to precision medicine. It determines eligibility for targeted therapies and immunotherapies, informs treatment selection, and ...
Continue reading
As the demand for personalized therapies continues to grow, trial designs must evolve to reflect the biological variability between patients. Traditional models...
Continue reading
On a recent episode of The Genetics Podcast, Patrick spoke with Daniel Geschwind, Senior Associate Dean and Associate Vice Chancellor of Precision Health at UCL...
Continue reading
News of a ‘CRISPR baby’ broke this week, almost seven years after the first CRISPR baby scandal unleashed a media frenzy and years of ethical debates. But this ...
Continue reading
Although long COVID cases have surged in recent years, the genetic factors that influence who develops the condition remain poorly understood. Traditional genom...
Continue reading
We’re proud to share that Sano Genetics plays a key role in the newly announced Lupus Nexus Foundational Analyses, a groundbreaking initiative led by the Lupus ...
Continue reading
Site disengagement can be a major barrier to successful and timely trial execution. A significant contributor to disengagement is overloading sites with redunda...
Continue reading
Clinical trial recruitment is notoriously difficult, and nowhere is this more acute than at the referral stage. When a participant who looks potentially eligibl...
Continue reading